Health

Vietnam able to produce COVID-19 treatment drug Molnupiravir

Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms, according to the Ministry of Health.
Vietnam able to produce COVID-19 treatment drug Molnupiravir ảnh 1Molnupiravir pills (Photo: VNA)
Hanoi (VNA) – Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms,according to the Ministry of Health.

Of the three, the drug manufactured by Stellapharm Vietnamhas been approved for clinical trial. Because Molnupiravir has yet been grantedwith a circulation registration number in Vietnam, the Ministry of Health isconsidering asking the Government for approval of using the drug inemergency cases. If approved by the Government, it is expected that three registrationnumbers will be issued for three types of Molnupiravir drugs manufactured by domesticpharmaceutical companies.

Regarding the effectiveness of Molnupiravir on COVID-19 patients in Vietnam,the Department of Science, Technology and Training under the Ministry of Healthsaid that from the end of August, the ministry has piloted using Molnupiravirfor non-hospitalised patients. Ho Chi Minh City was the first locality to implementthis pilot programme. At present, it has been arried out in 34 provinces andcities.

The ministry has provided 110,000 doses, including 50,000doses of Molnupiravir 400 mg Stella VN, and 60,000 doses of Molnupiravir 200 mgOptimus produced by India to localities.

The use of the drug in 22 provinces and cities showthat Molnupiravir is safe and well-accepted, and has obvious effectiveness inreducing viral load, virus spread and the number of severe cases, andshortening treatment time, with no fatalities recorded.

Molnupiravir is developed by the US-based pharmaceuticalcompanies Ridgeback Biotherapeutics and Merck & Co., Inc./.

VNA
#COVID-19 #Molnupiravir #COVID-19 patients #mild or no symptoms #Ministry of Health #Stellapharm Vietnam #Vietnam #Vietnamplus #Vietnam News Agency
Follow VietnamPlus

Related News

See more

The number of foreign tourists coming to Ho Chi Minh City for travel combined with medical check-ups is increasing. (Photo: VNA)

Vietnam looks to unlock medical tourism potential with national strategy

The draft strategy aims to position Vietnam as a trusted healthcare destination in Southeast Asia by 2030 and eventually among Asia's leading medical tourism hubs. The plan marks a shift from viewing medical tourism as an untapped opportunity to making it a national development priority.

Delegates at the conference. (Photo: VNA)

Vietnam to produce first homegrown next-generation vaccines from 2028

Under the agreement, Sanofi will transfer technology to VNVC to manufacture selected high-demand vaccines for children and adults at VNVC Vaccine and Bioproduct Plant. The first next-generation vaccines produced in Vietnam are expected to roll off production lines in 2028.

Eric and Alysha joyfully welcome their baby through Mini IVF after more than 10 years of waiting. (Photo: Hong Ngoc Phuc Truong Minh General Hospital)

Vietnam - a destination for journeys to parenthood

An increasing number of international families are choosing Vietnam for infertility treatment, embarking on journeys to parenthood that transcend geographical distance and differences in nationality.

Prime Minister Le Minh Hung delivers remarks at the inauguration ceremony for Viet Duc University Hospital's second campus in Ninh Binh province. (Photo: VNA)

PM urges modern restructuring of healthcare network

The PM stressed that throughout the country’s development process, people have consistently been regarded as the centre, the driving force, the objective and the most important resource for national development. Sustainable and rapid development requires not only a healthy, knowledgeable and skilled population but also a modern, equitable, efficient, sustainable and accessible healthcare system.

Thu Duc General Hospital, with a capacity of 1,000 beds, was inaugurated and put into operation in April 2025 (Photo: VNA)

Ho Chi Minh City moves to expand robotic surgery to gateway hospitals

According to the municipal Department of Health, developing gateway hospitals is a key pillar of the city's strategy to establish a regional specialised healthcare system. The network is designed to permanently relieve overcrowding at major downtown hospitals while strengthening strong inter-regional emergency care and treatment network.

Doctors conduct health screenings for children in Tru Van Tho commune, Ho Chi Minh City. (Photo :VNA)

Ho Chi Minh City moves closer to universal health check-ups

Achieving universal health check-ups in 2026 will lay the foundation for a new healthcare model in which every resident has an electronic health record, receives regular screenings, benefits from lifelong health management and gains access to early intervention through primary healthcare services.

Illustrative photo: Internet

Dengue cases rise, outbreaks become more unpredictable

Vo Hai Son, Deputy Director of the ministry's Administration of Disease Prevention, said dengue fever is no longer following previous epidemiological trends. In 2025, infections remained elevated through November and December rather than declining at the end of the year as had traditionally been the case, indicating a shortening outbreak cycle.